Related Experiment Videos
[Risk factors and preventive measures]
1Mitsukoshi Health and Welfare Foundation.
Insights
Lowering LDL cholesterol reduces coronary artery disease (CAD) risk. However, other factors like HDL, triglycerides, and Lp(a) also impact cardiovascular events, suggesting a broader approach to risk reduction.
Area of Science:
- Cardiovascular Medicine
- Lipidology
- Preventive Cardiology
Context:
- Clinical trials confirm LDL cholesterol reduction's role in decreasing coronary artery disease (CAD) risk.
- Statin therapy significantly lowers LDL but does not eliminate all cardiovascular events.
Purpose:
- To highlight the limitations of solely focusing on LDL cholesterol reduction for cardiovascular risk management.
- To advocate for the consideration of additional lipid and non-lipid parameters in assessing and mitigating CAD risk.
Summary:
- While statins effectively lower LDL cholesterol (24-37%), residual risk suggests other factors are crucial.
- Key parameters to consider include HDL cholesterol, triglycerides, lipoprotein(a) [Lp(a)], LDL particle size, and LDL oxidation susceptibility.
- Beyond lipids, fibrinolytic activity, hyperinsulinemia, hyperhomocysteinemia, and alcohol consumption are identified as significant contributing factors.
Impact:
- Broadens the understanding of cardiovascular risk beyond LDL cholesterol.
- Informs more comprehensive strategies for preventing coronary artery disease.
- Suggests a multi-faceted approach for maximizing therapeutic benefits in cardiovascular risk reduction.
Abstract:
Abundant clinical trial evidence supports the importance of LDL cholesterol-lowering in decreasing coronary artery disease (CAD) risk. Even in trials of statin therapy in which substantial reductions of LDL have been obtained, statin decrease by 24-37%, but do not entirely eliminate events. This is suggesting that other lipid parameters such as HDL, triglyceride, Lp(a), LDL particle size and susceptibility of LDL to oxidation should be considered. Furthermore, fibrinolytic activity, hyperinsulinemia, hyperhomocysteinemia and alcohol consumption should be also included as parameters to obtain significant benefit.